Research Center

Virus Like Particles

Virus-Like particles (VLP) consist of non-infectious empty viral capsids. These particles resemble the virus from wich they were derived but track viral nucleic acid, meaning that they are not infectious. 

These empty capsids can be easily manufactured in yeast and bacterial expression system. They are composed of multiple viral antigens lacking viral DNA or RNA.

Q-VLP Platform

VLPbio patented and propietary technology platform based on Virus Like Particles from Infectious Bursilitis (IBDV). IBDV belongs to the Birnaviridae family and its proteins, in particular VP2, has the ability to genereate viral like structures providing a versatile system for the incorporation of foreign peptides of interest, relevant to human disease in the form of a vaccine.

Cervivax

Propietary therapeutic Vaccine against Cervical Intrauterine Neoplastia based on Q-VLP propietary technology.

Technology Overview

  • 1

    Virus Like Particles

    Virus Like Particles (VLP) consist of non-infectious empty viral capsids. These particles resemble the virus from which they were derived but lack viral nucleic acid, meaning that they are not infectious.

  • 1

    Q-VLP Platform

    VLPbio patented and propietary technology platform based on Virus Like Particles derived from Infectious Bursal Disease Virus (IBDV)

  • 1

    Cervivax

    Propietary therapeutic Vaccine against Cervical Intrauterine Neoplastia based on Q-VLP propietary technology.